Literature DB >> 16047362

Alternative medicine remedies might stimulate viability of leukemic cells.

Jan Styczynski1, Mariusz Wysocki.   

Abstract

OBJECTIVE: Ex vivo activity of three products of alternative therapy against leukemic and normal cells was analyzed.
MATERIAL AND METHODS: Extracts of Viscum album, Uncaria tomentosa, and Croton lechleri were used for the study. Leukemic cells of 53 children with acute leukemias and four cell lines, Jurkat, CCRF-CEM, HL-60, and K-562 were tested for sensitivity to alternative medicine remedies by the MTT assay, cell-cycle analysis and annexin-V binding assay.
RESULTS: Leukemic cells showed high resistance to tested three compounds of alternative medicine in all performed assays. Additionally, tested remedies stimulated survival of leukemic cells in 45%, 96%, and 83% cases, respectively; while no effect was observed in normal lymphocytes. In combination studies, Viscum album extract did not increase prednisolone and cytarabine cytotoxicity in leukemic cells.
CONCLUSION: We conclude that some alternative medicine remedies might stimulate the viability of childhood leukemic cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16047362     DOI: 10.1002/pbc.20513

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  5 in total

Review 1.  Phytochemicals in the oncology setting.

Authors:  Catherine E Ulbricht; Wendy Chao
Journal:  Curr Treat Options Oncol       Date:  2010-12

2.  High prevalence of complementary and alternative medicine use in the Dutch pediatric oncology population: a multicenter survey.

Authors:  Maartje Singendonk; Gert-Jan Kaspers; Marianne Naafs-Wilstra; Antoinette Schouten-van Meeteren; Jan Loeffen; Arine Vlieger
Journal:  Eur J Pediatr       Date:  2012-09-19       Impact factor: 3.183

3.  Complementary and alternative medicine in patients with chronic lymphocytic leukemia.

Authors:  Manfred Hensel; Martin Zoz; Anthony D Ho
Journal:  Support Care Cancer       Date:  2008-05-06       Impact factor: 3.603

4.  Is there a role for complementary therapy in the management of leukemia?

Authors:  Kathleen M Wesa; Barrie R Cassileth
Journal:  Expert Rev Anticancer Ther       Date:  2009-09       Impact factor: 4.512

5.  Preferential Activity of Petiveria alliacea Extract on Primary Myeloid Leukemic Blast.

Authors:  Ricardo Ballesteros-Ramírez; Eliana Aldana; María Victoria Herrera; Claudia Urueña; Laura Yinneth Rojas; Luis Fernando Echeverri; Geison Modesti Costa; Sandra Quijano; Susana Fiorentino
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-11       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.